Journal of Cardiac Failure@JCardFail

Original peer-reviewed research & reviews #HeartSuccess @HFSA @JHeartFailureS @ElsevierConnect Co-EIC: @robmentz & @dranulala YouTube: tinyurl.com/jcf123

onlinejcf.com
Joined August 2013
795 Photos and videos
We are proud of the progress reflected in this year’s Impact Factor of 9.9, but even more proud of what all of this represents. A heartfelt THANK YOU to our entire JCF Family. Your engagement as authors, reviewers, readers, and mentors continues to drive this collective success.
14
36
18,303
📝Editorial perspective: The DCD juggernaut continues! As DCD moves from innovation to infrastructure, success must be measured beyond outcomes. Ethical stewardship, transparency, cost-effectiveness & preservation of public trust are critical to its future. 🧵👇
1
1
3
250
🔗 bit.ly/3SUAIIc

The DCD Juggernaut: How Donation After Circulatory Death Is Transforming the Cardiac Transplant...

One of the biggest challenges that a contemporary heart transplant center will encounter is the introduction and adoption of transplantation using donation after circulatory death (DCD) into its...

onlinejcf.com
51
🚨New Science Alert! 🫀DCD heart transplantation has expanded rapidly nationwide to more centers & higher-risk recipients. Yet graft failure, mortality & other early outcomes remained stable. This UNOS analysis supports the robustness & scalability of DCD. 🧵👇
2
5
11
1,150
🔗 bit.ly/3SOqgSx

Stable Outcomes of Donation After Circulatory Death Heart Transplantation From Early Adoption to...

Donation after circulatory death (DCD) heart transplantation has expanded rapidly in the United States, but whether outcomes have evolved during national dissemination remains uncertain. Given the...

onlinejcf.com
1
142
🌍How do countries decide who gets a donor heart first? This research article analyzes heart allocation policies globally. Across 29 countries, 93% of allocation systems use urgency tiers. But how urgency, MCS priority, & exceptions are defined varies widely. 🧵👇
2
4
13
719
more replies
📝 Editorial perspective: Structural objectivity ≠ moral objectivity. Clear allocation rules make value judgments visible. They don't eliminate them. The next challenge: designing systems that reduce waitlist mortality, improve equity & sustain public trust.🫀 🧵👇
1
1
235
🔗 bit.ly/3SY4mMx

Beyond Sickest-First: What Heart-Allocation Systems Reveal About Our Definition of Fairness

Every day, transplant teams around the world face the same impossible decision.

onlinejcf.com
47
⏰Final Call Submissions for JCF's Focus Issue: The New Frontier of Heart Function in Women close soon. If your research advances women's cardiovascular health, now's the time to submit. 📅 Submissions close tomorrow, 9/15/26 bit.ly/4xQkPSR #WomensHeartHealth
7
12
3,308
🫀 Heart transplantation is entering a new era! This State-of-the-Art review explores advances reshaping the field: individualized LVAD vs transplant decisions, DCD & HCV+ donors, and new organ preservation strategies expanding the donor pool. 🔗 bit.ly/45xVQXm 🧵👇
2
13
27
2,082
And the evolution continues after transplant: noninvasive rejection surveillance, precision immunosuppression, and greater focus on long-term allograft survival. And on the horizon: xenotransplantation. 🔬🫀 A must-read article!
156
What's next in heart transplantation? 🫀 Find out in the September Focus Issue on Innovations in Heart Transplantation. Explore research and perspectives on new developments advancing heart transplantation care. 🔗 onlinejcf.com/current #HeartTransplantation #Cardiology
10
14
3,427
🚨New science alert! PAWP or LVEDP ... which better predicts outcomes? Using simultaneous invasive hemodynamics at rest & during exercise, this study found that PAWP better reflected hemodynamic abnormalities & predicted adverse HF outcomes. 🫀 🔗 bit.ly/4x64Z5K
1
9
19
1,865
📝 Editorial perspective Discordance between PAWP and LVEDP shouldn't simply lead us to discount LVEDP. Instead, the pressure difference may offer important clues to underlying pathology affecting left atrial function. 🫀 🔗 bit.ly/4ibdM1p @MicheleEmdin
5
6
290
⏳ The deadline is approaching. JCF is still accepting submissions for the Focus Issue: The New Frontier of Heart Function in Women. If your research advances women's cardiovascular health, we encourage you to submit by 9/15/26. bit.ly/4xQkPSR
3
3
614
🧬Precision medicine begins with a diagnosis. In the largest real-world study to date, only 1.05% of patients with cardiomyopathy underwent genetic testing and just 7% received genetic counseling. Implementation — not evidence — remains the challenge. 🔗 bit.ly/4qpMbvF
2
7
506
🫀🧬 Is suPAR more than a biomarker? In SOLOIST-WHF, higher baseline suPAR predicted worse HF outcomes, but sotagliflozin reduced events regardless of suPAR and did not lower suPAR levels — pointing to residual inflammatory risk. 🔗 bit.ly/4qjyrT0
1
5
10
948
📝 Editorial perspective suPAR may represent more than prognostic information; it may identify an inflammatory pathway not addressed by current GDMT. The next frontier may be targeting residual inflammatory risk in HF. 🧬🫀 🔗 bit.ly/3TSKOJR
1
2
118
🫀Does transplant center volume influence DCD heart transplant outcomes? This UNOS analysis found similar perioperative outcomes and short-term survival at high & low-volume centers, supporting the growing robustness & reproducibility of DCD transplantation. 🧵👇
3
1
6
797
🔗 bit.ly/3U4HUl9
1
1
237
📝 Editorial perspective DCD heart transplantation shouldn't be limited to high-volume centers. With standardized procurement, appropriate infrastructure & shared expertise, broader adoption could reduce geographic disparities & improve access. 🫀 🔗 bit.ly/4658cGz
1
2
188
Load more